D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model ; volume:6 ; number:1 ; day:27 ; month:4 ; year:2018 ; pages:1-12 ; date:12.2018
Acta Neuropathologica Communications ; 6, Heft 1 (27.4.2018), 1-12, 12.2018
- Urheber
-
Kim, Donghoon
- Beteiligte Personen und Organisationen
-
Hwang, Heehong
Choi, Seulah
Kwon, Sang Ho
Lee, Suhyun
Park, Jae Hong
Kim, SangMin
Ko, Han Seok
SpringerLink (Online service)
- DOI
-
10.1186/s40478-018-0538-9
- URN
-
urn:nbn:de:101:1-2018070116082750042837
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kim, Donghoon
- Hwang, Heehong
- Choi, Seulah
- Kwon, Sang Ho
- Lee, Suhyun
- Park, Jae Hong
- Kim, SangMin
- Ko, Han Seok
- SpringerLink (Online service)
Ähnliche Objekte (12)
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
Alcohol consumers with liver pathology rarely display α-synuclein pathology
α-Synuclein serine129 phosphorylation – the physiology of pathology
Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils
Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice
LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice
Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
![The relationship between α-synuclein [alpha-synuclein] and the proteasome and its role in Parkinson's pathology](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
The relationship between α-synuclein [alpha-synuclein] and the proteasome and its role in Parkinson's pathology
Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology
Hippocampal subfield vulnerability to α-synuclein pathology precedes neurodegeneration and cognitive dysfunction
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
Alcohol consumers with liver pathology rarely display α-synuclein pathology
α-Synuclein serine129 phosphorylation – the physiology of pathology
Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils
Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice
LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice
Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
The relationship between α-synuclein [alpha-synuclein] and the proteasome and its role in Parkinson's pathology
Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology
Hippocampal subfield vulnerability to α-synuclein pathology precedes neurodegeneration and cognitive dysfunction
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
Alcohol consumers with liver pathology rarely display α-synuclein pathology
α-Synuclein serine129 phosphorylation – the physiology of pathology
Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils
Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice
LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice
Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
The relationship between α-synuclein [alpha-synuclein] and the proteasome and its role in Parkinson's pathology
Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology